prostate cancer | Research | Treatment | 10 pages | source: European urology focus | Added May 14, 2023
Comparing the effectiveness and safety of prostate-only versus pelvic radiotherapy for patients with prostate cancer spread to nearby lymph nodes.
This study compared the safety and effectiveness of whole-pelvis radiotherapy (WPRT) and prostate-only radiotherapy (PORT) in patients with node-positive prostate cancer (PC) (PC that has spread to nearby lymph nodes). The study found that WPRT improves survival without relapse in these patients, with more short-term gastrointestinal side effects.
prostate cancer | Research | 10 pages | source: The Oncologist | Added Sep 01, 2022
Evaluating depression, anxiety, and patterns of mental health care in patients with prostate cancer receiving hormone therapy
This study evaluated depression, anxiety, and patterns of mental health care in patients with prostate cancer receiving hormonal therapy such as androgen deprivation therapy (ADT). The data showed that almost half of the patients with prostate cancer receiving ADT diagnosed with depression do not receive a documented mental health treatment.
prostate cancer | Research | Treatment | 10 pages | source: Frontiers in oncology | Added Jan 09, 2022
Comparing the effectiveness of PARP inhibitors for the treatment of patients with BRCA1 and BRCA2 mutations.
This study compared the effectiveness of PARP inhibitors for the treatment of patients with BRCA1 and BRCA2 mutations in solid tumors. The data showed that PARP inhibitors could benefit both patients with BRCA1 and BRCA2 mutations with similar effectiveness.
prostate cancer | Research | Treatment | 10 pages | source: The Lancet. Oncology | Added Feb 26, 2021
Evaluating the effectiveness and safety of stereotactic ablative body radiotherapy in advanced cancer
This study investigated the effectiveness and safety of stereotactic ablative radiation therapy (SABR) in the treatment of patients with oligometastatic (few metastases) cancer. The data showed that the use of SABR in these patients was associated with high overall survival and low toxicity.
prostate cancer | Research | Treatment | 10 pages | source: The Lancet. Oncology | Added Jan 12, 2020
The role of androgen deprivation therapy plus radiotherapy in the treatment of prostate cancer after prostate surgery
This study compared the safety and effectiveness of short-term androgen deprivation therapy (ADT) combined with radiotherapy (RT) in patients who underwent radical prostatectomy (RP). The main finding was that the combination of ADT and RT reduced the risk of recurrence and disease progression in these patients.
prostate cancer | Research | 10 pages | source: International Journal of Cancer | Added Apr 15, 2019
Can environmental chemicals increase the risk of prostate cancer returning?
This study examined if exposure to certain environmental chemicals is linked to prostate cancer recurrence. This study concluded that environmental estrogens may increase the risk of prostate cancer recurrence.
prostate cancer | Community | 0 pages | source: The Harris Poll | Added Nov 05, 2018
Nocturia: Most Americans never heard of it
prostate cancer | Research | 10 pages | source: Cancer | Added Jan 17, 2018
Post-traumatic stress disorder can develop in patients with cancer
This study aimed to evaluate post-traumatic stress disorder (PTSD) in patients who have had treatment for cancer. This study found that a number of patients undergoing cancer treatment developed PTSD after treatment and recommended that supports are put in place.
prostate cancer | Research | 8 pages | source: Cancer | Added Dec 31, 2017
Video tools can be used improve patient knowledge of prostate terminology
The authors aimed to determine the effectiveness of video tools in improving patient knowledge of common prostate terminology.
prostate cancer | Research | 12 pages | source: Urology | Added Dec 24, 2017
How often does the urethra become blocked following prostate cancer treatment?
The authors evaluated the prevalence and management of urethral blockage following certain cancer treatments.